A prospective study of the use of CFTR modulators during pregnancy and lactation is greatly needed so that providers can offer informed discussions to women with CF who must make this difficult choice to continue or discontinue CFTR modulators prior to attempting pregnancy or during pregnancy. This evidence concerns the gene CFTR and cystic fibrosis.